In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 483-489

  Uherova, Patricia ^a   Connick, Elizabeth ^a   Mawhinney, Samantha ^a   Schlichtemeier, Rick ^a   Schooley, Robert T ^a   Kuritzkes, Daniel R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 12; STREPTOKINASE; TETANUS TOXOID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOREACTIVITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

EID: 0029741444     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.483     Document Type: Article

References (25)

1. Rook AH, Masur H, Lane HC, et al. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immunodeficiency syndrome. J Clin Invest 1983;72:398-403.
2. Lane HC, Masur H, Edgar LC, Whalen G, Waldmann TA, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-8.
3. Miedema F, Chantai Petit AJ, Terpstra FG, et al. Immunological abnormalities in human immunodeficiency virus-infected asymptomatic homosexual men. J Clin Invest 1988;82:1908-14.
4. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;313:79-84.
5. Shearer G, Clerici M. Early T-helper cell defects in HIV infection. AIDS 1991;5:245-53.
6. Shearer GM, Bernstein DC, Tung KS. A model for the selective loss of major histocompatibility self-restricted T-cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986;137:2514-21.
7. Clerici M, Stocks NI, Zajac RA. Detection of three distinct patterns of T-helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989;84:1892-9.
8. + cells of the CD4 and CDS lineages. AIDS 1993;7:613-24.
9. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-46.
10. Chehimi J, Starr S, Frank I, et al. Natural killer stimulatory factor (NKSF) increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients. J Exp Med 1992;175:789-96.
11. Chehimi J, Valiante NM, D'Andrea A, et al. Enhancing effect of natural killer cell stimulatory factor (NKSF/IL12) on cell mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 1993;23:1826-30.
12. Wu CY, Demerue C, Kiniwa M, Gately M, Delespesse G. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J Immunol 1993;151:1938-49.
13. Chehimi J, Clerici M. Interleukin 12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol 1994;14:149-61.
14. + T lymphocytes and NK cells. J Immunol 1992;149:3495-502.
15. Gately KM, Desai BB, Wolitzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991;147:874-82.
16. Jassoy C, Harrer T, Rosenthal T, et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release γ interferon, tumor necrosis factor α (TNF-α), and TNF-β when they encounter their target antigens. J Virol 1993;67:2844-52.
17. Clerici M, Lucey DR, Berzofsky JA, et al. Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-4.
18. Newman GW, Guamaccia JR, Vance EA, Wu JY, Remold HG, Kazanjian PJ. Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS 1994;8:1413-9.
19. Seder RA, Grabstien KH, Berzofsky JA, McDyer JF. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med 1995;182:1067-78.
20. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies: I. data analysis. J Immunol 1981;126:1614-9.
21. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
22. Foli A, Saville MW, Baseler MW, Yarchoan R. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 1995;85:2115-23.
23. McLeod GX, Hammer SM. Effects of interleukin-12 on HIV-1 replication in vitro [abstract 356]. In: Program and abstracts of the First National Conference on Human Retroviruses and Related Infections (Washington, DC). Washington, DC: American Society for Microbiology, 1993.
24. Nokta M, Turk P, Locsch K, Mallen M, Bay S, Pollard R. Effect of IL-12 on type I and type 2 responses in peripheral blood mononuclear cells (PBMC) from HIV infected patients [abstract 338]. In: Program and abstracts of the Keystone Symposium on Molecular and Cellular Biology: Immunopathogenesis of HIV Infection (Hilton Head, SC). Silverthorne, CO: Keystone Symposia, 1996.
25. Radrizzani M, Accornero P, Amidei A, et al. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/ TCR activation or by IL-2 deprivation. Cell Immunol 1995;161:14-21.